NO20025399D0 - Fosfat transport inhibitorer - Google Patents

Fosfat transport inhibitorer

Info

Publication number
NO20025399D0
NO20025399D0 NO20025399A NO20025399A NO20025399D0 NO 20025399 D0 NO20025399 D0 NO 20025399D0 NO 20025399 A NO20025399 A NO 20025399A NO 20025399 A NO20025399 A NO 20025399A NO 20025399 D0 NO20025399 D0 NO 20025399D0
Authority
NO
Norway
Prior art keywords
transport inhibitors
phosphate transport
phosphate
inhibitors
transport
Prior art date
Application number
NO20025399A
Other languages
English (en)
Norwegian (no)
Other versions
NO20025399L (no
Inventor
Joseph Weinstock
Gerald Girard
Dimitri Gaitanopoulos
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20025399L publication Critical patent/NO20025399L/no
Publication of NO20025399D0 publication Critical patent/NO20025399D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
NO20025399A 2000-05-12 2002-11-11 Fosfat transport inhibitorer NO20025399D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20399500P 2000-05-12 2000-05-12
PCT/US2001/015324 WO2001087294A1 (en) 2000-05-12 2001-05-11 Phosphate transport inhibitors

Publications (2)

Publication Number Publication Date
NO20025399L NO20025399L (no) 2002-11-11
NO20025399D0 true NO20025399D0 (no) 2002-11-11

Family

ID=22756167

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025399A NO20025399D0 (no) 2000-05-12 2002-11-11 Fosfat transport inhibitorer

Country Status (14)

Country Link
JP (1) JP2003533477A (cs)
KR (1) KR20020093983A (cs)
CN (1) CN1429108A (cs)
AU (1) AU2001261471A1 (cs)
BR (1) BR0110034A (cs)
CA (1) CA2408667A1 (cs)
CZ (1) CZ20023701A3 (cs)
HU (1) HUP0302234A2 (cs)
IL (1) IL152587A0 (cs)
MX (1) MXPA02011160A (cs)
NO (1) NO20025399D0 (cs)
PL (1) PL359931A1 (cs)
WO (1) WO2001087294A1 (cs)
ZA (1) ZA200209106B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2378179A (en) * 2001-08-03 2003-02-05 Pantherix Ltd Aromatic sulfonamides and their use in treating bacterial diseases
US7119120B2 (en) * 2001-12-26 2006-10-10 Genzyme Corporation Phosphate transport inhibitors
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
MX2011007024A (es) 2008-12-31 2011-09-27 Aedelyx Inc Compuestos y metodos para inhibir el antiporte mediado por intercambiador de iones de sodio/iones de hidrogeno (nhe) en el tratamiento de trastornos asociados con retencion de fluido o sobrecarga de sal y trastornos del tracto gastrointestinal.
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
MX366293B (es) 2012-08-21 2019-07-04 Ardelyx Inc Compuestos y metodos para inhibir al antipuerto mediado por nhe en el tratamiento de trastornos asociados con la retencion de fluidos o la sobrecarga de sal y trastornos del tracto gastrointestinal.
CN103183623A (zh) * 2013-03-12 2013-07-03 中国医学科学院医药生物技术研究所 一组苯磺酰胺基苯甲酰胺类衍生物及制备和应用
KR20250026881A (ko) 2013-04-12 2025-02-25 알데릭스, 인코포레이티드 Nhe3-결합 화합물 및 포스페이트 수송을 저해하는 방법
US9765050B2 (en) 2014-12-30 2017-09-19 Novira Therapeutics, Inc. Pyridyl reverse sulfonamides for HBV treatment
CN105395532B (zh) * 2015-11-25 2017-11-14 中国医学科学院医药生物技术研究所 2‑苯磺酰胺基苯甲酰胺类化合物在肝损伤保护和肝纤维化防治中的应用
WO2018043400A1 (ja) * 2016-08-30 2018-03-08 日本曹達株式会社 スルホニルアミノベンズアミド化合物および有害生物防除剤
MA47203A (fr) 2017-01-09 2019-11-13 Ardelyx Inc Inhibiteurs d'antiport à médiation par nhe
MX395405B (es) 2017-01-09 2025-03-25 Ardelyx Inc Compuestos útiles para tratar trastornos del tracto gastrointestinal.
US11390599B2 (en) 2018-06-01 2022-07-19 Promega Corporation Inhibitors of oplophorus luciferase-derived bioluminescent complexes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL146513A0 (en) * 1999-06-24 2002-07-25 Smithkline Beecham Corp Macrophage scavenger receptor antagonists
AR030911A1 (es) * 1999-07-20 2003-09-03 Smithkline Beecham Corp Uso de n-aril-2-sulfonamidobenzamidas para la manufactura de un medicamento para el tratamiento de la insuficiencia renal cronica y composiciones farmaceuticas

Also Published As

Publication number Publication date
BR0110034A (pt) 2003-05-27
JP2003533477A (ja) 2003-11-11
CN1429108A (zh) 2003-07-09
WO2001087294A1 (en) 2001-11-22
NO20025399L (no) 2002-11-11
ZA200209106B (en) 2003-10-23
PL359931A1 (en) 2004-09-06
AU2001261471A1 (en) 2001-11-26
CZ20023701A3 (cs) 2003-11-12
IL152587A0 (en) 2003-05-29
CA2408667A1 (en) 2001-11-22
HUP0302234A2 (hu) 2003-11-28
KR20020093983A (ko) 2002-12-16
MXPA02011160A (es) 2003-03-10

Similar Documents

Publication Publication Date Title
DE60002193D1 (de) Metalloprotease inhibitoren
ATE433451T1 (de) Xanthin-phosphodiesteras-v-inhibitoren
ATE285821T1 (de) Fab i inhibitoren
AR028253A1 (es) Inhibidores de la glucogeno fosforilasa
CY2012007I2 (el) Πεπτιδομιμητικοι αναστολεις πρωτεασης
ATE318603T1 (de) Pyrrolotriazin kinasehemmer
DE60234125D1 (de) E inhibitoren
PT1370553E (pt) Inibidores de rhoquinase
PT1194404E (pt) Inibidores de aspartil-protease
DK1272488T3 (da) Tri-aryl-substitueret ethan-PDE4-inhibitorer
NO20014243D0 (no) Dihetero-substituerte metalloprotease inhibitorer
NO20025399L (no) Fosfat transport inhibitorer
NO20014875D0 (no) Promedikamenter for trombin inhibitorer
DE50108962D1 (de) Transportanlage
ATE252547T1 (de) Matrixmetalloproteinaseinhibitoren
NO20025786L (no) Protaseinhibitorer
PT1339695E (pt) Inibidores da farnesiltransferase
NO20024481D0 (no) Difluorbutyrsyre metalloproteaseinhibitorer
NO20025005L (no) Proteaseinhibitorer
IS6701A (is) Cdc25 fosfatasahemlar
DK1130214T3 (da) Korrosionsinhibitorer
AR028075A1 (es) Inhibidores de la peptido-desformilasa
DE60132468D1 (de) Alen-lanosterol zyklase inhibitoren
NO20032328D0 (no) Proteaseinhibitorer
ATA11912000A (de) Transportanlage

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application